Aerosol delivery through tracheostomy tubes: An in vitro study

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 26, Issue 2, 2013, Pages 76-83

  Pitance, L ^a,b   Vecellio, L ^c,d   Delval, G ^e   Reychler, G ^a,b   Reychler, H ^a   Liistro, G ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITÉ DE TOURS   (France)

^d Laboratory of Microbiology CNRS UMR 7276 Faculties of Medicine and Pharmacy   (France)

^e Division of Podiatry   (Belgium)

Author keywords

Aerosol; Cannula; In vitro; Jet nebulizer; Tracheostomy

Indexed keywords

AMIKACIN;

AEROSOL; ARTICLE; BREATHING; HUMAN; IN VITRO STUDY; LUNG MODEL; NEBULIZATION; NEBULIZER; PARTICLE SIZE; TRACHEOSTOMY; TRACHEOSTOMY TUBE;

ADMINISTRATION, INHALATION; AEROSOLS; AMIKACIN; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; MODELS, ANATOMIC; NEBULIZERS AND VAPORIZERS; TRACHEOSTOMY;

EID: 84876037674     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0962     Document Type: Article

References (37)

1. Durbin CG Jr: Indications for and timing of tracheostomy. Respir Care. 2005;50:483-487.
2. Ak O, Batirel A, Ozer S, and Colakoglu S: Nosocomial infections and risk factors in the intensive care unit of a teaching and research hospital: a prospective cohort study. Med Sci Monit. 2011;17:H29-H34.
3. Lu Q, Yang J, Liu Z, Gutierrez C, Aymard G, and Rouby JJ: Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Am J Respir Crit Care Med. 2011;184:106-115.
4. Boe J, Dennis JH, O'Driscoll BR, Bauer TT, Carone M, Dautzenberg B, Diot P, Heslop K, and Lannefors L: European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J. 2001;18:228-242.
5. Rouby JJ: Nosocomial infection in the critically ill: the lung as a target organ. Anesthesiology. 1996;84:757-759.
6. Goldstein I, Wallet F, Robert J, Becquemin MH, Marquette CH, and Rouby JJ: Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med. 2002;165:171-175.
7. Willis LD, and Berlinski A: Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care. 2012 [Epub ahead of print].
8. Stahlhofen W, Gebhart J, and Heyder J: Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am Ind Hyg Assoc J. 1980;41: 385-98a.
9. Nikander K, Berg E, and Smaldone GC: Jet nebulizers versus pressurized metered dose inhalers with valved holding chambers: effects of the facemask on aerosol delivery. J Aerosol Med. 2007;20 Suppl 1:S46-S55.
10. Lin HL, Restrepo RD, Gardenhire DS, and Rau JL: Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care. 2007;52: 1021-1026.
11. Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, and Wildhaber JH: Facemasks and aerosol delivery in vivo. J Aerosol Med. 2007;20 Suppl 1:S78-S83. 12a. Hakkinen AM, Uusi-Heikkila H, Jarvinen M, Saali K, and Karhumaki L: The effect of breathing frequency on deposition of drug aerosol using an inhalation-synchronized dosimeter in healthy adults. Clin Physiol. 1999;19:269-274. 12b. Majoral C, Vecellio L, Grimbert D, De Monte M, Le Guellec C, Ingremeau V, Minois C, Cordeau E, Paintaud G, and Diot P: New ipratropium formulation to decrease nebulization time. Respir Med. 2007;101:237-245.
12. Majoral C, Vecellio L, Grimbert D, De Monte M, Le Guellec C, Ingremeau V, Minois C, Cordeau E, Paintaud G, and Diot P: New ipratropium formulation to decrease nebulization time. Respir Med. 2007;101:237-245.
13. Martonen TB, and Katz IM: Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters. Pharm Res. 1993;10:871-878.
14. Newman SP, Woodman G, and Clarke SW: Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax. 1988;43:318-322.
15. Valberg PA, Brain JD, Sneddon SL, and LeMott SR: Breathing patterns influence aerosol deposition sites in excised dog lungs. J Appl Physiol. 1982;53:824-837.
16. O'Riordan TG, Palmer LB, and Smaldone GC: Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med. 1994;149:214-219.
17. Ari A, and Fink JB: Factors affecting bronchodilator delivery in mechanically ventilated adults. Nurs Crit Care. 2010;15:192-203.
18. Dhand R: Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv. 2008;21:45-60.
19. Ahrens RC, Ries RA, Popendorf W, and Wiese JA: The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol. 1986;2:19-26.
20. Coleman DM, Kelly HW, and McWilliams BC: Therapeutic aerosol delivery during mechanical ventilation. Ann Pharmacother. 1996;30:644-655.
21. MacIntyre NR, Silver RM, Miller CW, Schuler F, and Coleman RE: Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med. 1985;13:81-84.
22. Pedersen KM, Handlos VN, Heslet L, and Kristensen HG: Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a highfrequency vibrating mesh nebulizer. J Aerosol Med. 2006; 19:175-183.
23. Ari A, Harwood R, Sheard M, and Fink JB: An in-vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care. 2012. [Epub ahead of print].
24. Blau H, Mussaffi H, Mei Zahav M, Prais D, Livne M, Czitron BM, and Cohen HA: Microbial contamination of nebulizers in the home treatment of cystic fibrosis. Child Care Health Dev. 2007;33:491-495.
25. Piccuito CM, and Hess DR: Albuterol delivery via tracheostomy tube. Respir Care. 2005;50:1071-1076.
26. de Boer AH, Gjaltema D, Hagedoorn P, Schaller M, Witt W, and Frijlink HW: Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. Int J Pharm. 2002;249:233-245.
27. Pitance L, Vecellio L, Leal T, Reychler G, Reychler H, and Liistro G: Delivery efficacy of a vibrating mesh nebulizer and a jet nebulizer under different configurations. J Aerosol Med Pulm Drug Deliv. 2010;23:389-396.
28. Reychler G, Wallemacq P, Rodenstein DO, Cumps J, Leal T, and Liistro G: Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. J Aerosol Med. 2006;19:199-207.
29. Hess DR: Tracheostomy tubes and related appliances. Respir Care. 2005;50:497-510.
30. Cowan T, Op't Holt TB, Gegenheimer C, Izenberg S, and Kulkarni P: Effect of inner cannula removal on the work of breathing imposed by tracheostomy tubes: a bench study. Respir Care. 2001;46:460-465.
31. Dhand R: Special problems in aerosol delivery: artificial airways. Respir Care. 2000;45:636-645.
32. Crogan SJ, and Bishop MJ: Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology. 1989;70:1008-1010.
33. Smaldone GC: Advances in aerosols: adult respiratory disease. J Aerosol Med. 2006;19:36-46.
34. Dolovich M: Physical principles underlying aerosol therapy. J Aerosol Med. 1989;2:171-186.
35. O'Riordan TG, Greco MJ, Perry RJ, and Smaldone GC: Nebulizer function during mechanical ventilation. Am Rev Respir Dis. 1992;145:1117-1122.
36. Pisut FM: Comparison of medication delivery by T-nebulizer with inspiratory and expiratory reservoir. Respir Care. 1989;34:985-988.
37. Piper SD: In vitro comparison of the Circulaire and Aero-Tee to a traditional nebulizer T-piece with corrugated tubing. Respir Care. 2000;45:313-319.